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Introduction
In neurophysiology, localizing neuronal activity, especially epileptic seizures, is of great
importance (Bahar et al., 2006; Bhatia et al., 2008; Cang et al., 2005; Fisher et al., 2004;
Hielscher et al., 2002; Inyushin et al., 2010). In clinical practice, functional magnetic
resonance imaging (fMRI) (Salek-Haddadi et al., 2003), positron emission tomography
(PET) ( Dedeurwaerderte et al, 2005; Sheth et al., 2009), optical coherence tomography
(Srinivasan et al., 2010), and near-infrared spectroscopy (Hielscher et al., 2002; Lee et al.,
2010) have all been used to locate epileptic foci. In preclinical studies, intrinsic optical
signal imaging (IOS) (Inyushin et al., 2001; Ma et al., 2009; Tsytsarev et al., 2008) and
voltage-sensitive dye optical imaging (VSD) have also been demonstrated for this purpose
(Fisher et al., 2004 and 2008; Kameyama et al., 2008; Takagaki et al, 2011; Tsytsarev et al.,
2006 and 2010).
In mammals, glucose is the primary energy source. Complete oxidation of glucose produces
CO2, water, and adenosine triphosphate (ATP). ATP can be used by any type of cells,
including neurons and astrocytes (Nitin et al., 2009; Rouach et al., 2008). Perfusion-based
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brain imaging, which relies on the coupling between neuronal activity and glucose
metabolism (Millon et al., 2011; Ito et al., 2006; Itoh et al., 2004; Inyushin et al., 2010), has
become a popular method to localize epileptic foci by using derivatives of 2-deoxyglucose
(2-DG). Among these, fluorodeoxyglucose (18F) (FDG), a glucose analog with the
radioactive isotope fluorine-18 substituted for the normal hydroxyl in the glucose molecule,
is widely used in PET studies (Imamura et al., 2009; Katsuyama et al., 2010). Once injected
into the body, FDG can be taken up by cells, where phosphorylation prevents it from being
released again from the cells. However, because of the lack of the 2′ hydroxyl group needed
for glycolysis, FDG cannot be further metabolized (Millon et al., 2011; Sheth et al., 2009).
Therefore, the distribution of the trapped FDG is a good reflection of glucose metabolism.
However, the ionizing radiation of FDG limits its repetitive usage.
Fluorescent 2-DG derivatives can act like FDG without the radiation concern (Yamada et
al., 2009). In our study, we employed a fluorescent 2-DG analog, 2-(N-(7-nitrobenz-2-
oxa-1,3-diazol-4-yl)amino)-2-deoxyglucose (2-NBDG), for visualization of in vivo epileptic
activities induced by intracortical injection of 4-aminopyridine (4-AP). The increased uptake
rate of 2-NBDG at the injection site of 4-AP reflected elevated cell metabolism caused by
epileptic seizures. The results demonstrate that 2-NBDG has the potential to be used as a
contrast agent to image epileptic seizures in vivo.
Materials and Methods
2-NBDG synthesis
The synthesis of 2-NBDG (Figure 1) was carried out using a modified procedure originally
developed by Yamada et al., 2009). D-Glucosamine hydrochloride (1 g, 4.63 mM) was
dissolved in methanol (10 mL), and NaHCO3 (0.97 g) was added. The resulting mixture was
stirred for 15–20 min. Then 1.11 g of 4-chloro-7-nitrobenzofuran (NBDCl) (5.56 mM) was
added, and the reaction mixture was first stirred for 5 min at room temperature and then for
an additional 45 min at 50 °C. After that, the solids were filtered out and the filtrate was
concentrated in vacuo. The residue was purified by column chromatography, first on silica
gel (methanol/dichloromethane gradient elution) and then on Sephadex LH-20 (methanol/
dichloromethane, 1/1, v/v isocratic elution) (Bem et al., 2007). Pure fractions were
combined and concentrated, and the residue was lyophilized from water to give 2-NBDG
(200 mg, 13% yield) as an orange-red amorphous solid. The analytical data was essentially
the same as reported previously by Yamada et al. (Yamada et al., 2009).
Fluorescence imaging system setup
The fluorescence imaging system is shown in Figure 2. The light source was a 120-W xenon
arc lamp with two excitation filters (450 nm ± 40 nm). Fluorescent images were captured by
a low noise CCD camera. A 4× objective (NA: 0.1) with an emission filter (550 nm ± 40
nm) and an achromatic doublet (focal length: 100 mm) comprised the camera lens. The CCD
camera was positioned above the brain chamber, with its optical axis adjusted to be as
closely perpendicular to the cortical surface as possible. The focal plane was 500 μm below
the surface of the dura mater (Bahar et al., 2006; Yang et al., 2003).
Animal preparations
For each experiment, a Sprague-Dawley adult rat (male, 250–350 g, 2–3 months) was
anesthetized by an IP injection of a mixture of ketamine (90 mg/kg) and xylazine (12 mg/kg)
and fixed onto an animal holder (Hu et al., 2009; Tsytsarev et al., 2011). Throughout the
experiment, the animal was supplied with breathing grade compressed air (AI B300, Airgas,
MO) and maintained under anesthesia using isoflurane (1.0–1.5% with an airflow rate of ~1
L/min). The body temperature of the animal was maintained at 37 °C by a temperature-
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controlled electrical heating pad. The hair on the scalp was removed using an electric
shaver, and the scalp was incised along the midline. At the dorsal part of the skull, a cranial
window of ~6–8 mm2 was opened using a dental drill (Figure 2, inset) (Tsytsarev et al.,
2008).
A chamber made of silicone was placed above the cranial window. To suppress cortical
tissue motion induced by respiratory and cardiovascular movements, the chamber was filled
with high density silicone oil and then sealed with a cover glass. For the later continuous
injection of 2-NBDG, a lateral tail vein was punctured with a sterile catheter after the tail
was heated by warm water (35–40 °C). A cannula was inserted into the tail vein and fixed
onto the tail with adhesive tape. At the end of each experiment, the animal was sacrificed by
an overdose of Nembutal (200 mg/kg). All procedures were carried out according to the
standards of the Animal Studies Committee of Washington University in St. Louis.
Inducement of epileptic seizures
After craniotomy, two intracortical injections were made. The first was 0.5 μL of 25 mM
solution of 4-AP in artificial cerebrospinal fluid (ACSF), which was used to induce local
epileptic seizures (Bahar et al., 2006; Yang et al., 2003). The second, as a control, was the
same volume of ACSF, located 2–3 mm from the injection site of 4-AP. Both injections
were done by an injector device (Nanojet II) with a 15–25 μm diameter glass microcapillary.
The injector was mounted on a micromanipulator that allowed precise injections 0.5 mm
below the surface (5, 7).
Fluorescence imaging of 2-NBDG
Following the injections of 4-AP and ACSF, fluorescent images of the cerebral cortex were
captured every 20 s, with an exposure time of 10 s. Images were automatically saved for
later analysis. After 10 minutes, a total of 2 mL of 1% solution of 2-NBDG in Ringer’s
solution for mammals was continuously injected through the implanted catheter, driven by a
syringe pump (Harvard Apparatus). The whole injection took ~15 min at a rate of 0.14 mL/
min. Here, a slow, continuous injection was necessary to prolong the circulation time of 2-
NBDG and thus help it reach brain cells (Yamada et al., 2009; Sheth et al., 2009).
Image processing
The fluorescence images were analyzed off-line, using an algorithm developed in MATLAB
(R2008a, Mathworks). At each time point, the averaged fluorescence intensity of the pixels
within 1 mm of the injection sites of 4-AP and ACSF were quantified and normalized to the
mean baseline value acquired before the injection of 2-NBDG. The stabilization time, during
which the fluorescence intensity reached 90% of the maximum, was calculated for the two
injection sites. The quantification results are shown as means with standard deviation, N = 5.
The statistical test was a paired Student’s t-test. We considered a p-value less than 0.05 to be
significant.
Results
As shown in Figure 3 and Figure 4(A), before the injection of 2-NBDG (0–10 min),
fluorescence intensity in the field of view (FOV) was minimal, which indicated relatively
little autofluorescence. After the injection of 2-NBDG, the fluorescence intensity in the FOV
increased globally. The cortical cells appeared to rapidly take up 2-NBDG and retain it
within the cytoplasm. The initial increase rate around the injection site of 4-AP was
significantly greater than that around the injection site of ACSF [Figure 4(B)], which
reflected a faster uptake of 2-NBDG and thus a greater glucose metabolism. Such
hypermetabolism indicated increased neuron activity caused by local epileptic seizures.
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Moreover, the maximum fluorescence intensity in the area of the epileptic seizures was also
higher than that of the control area [Figure 4(A)]. In our experiments, epileptic foci were
clearly marked by such stronger fluorescence signals.
Blood vessels appeared dark in the fluorescence images, because fluorescence emitted by 2-
NBDG was mostly absorbed by hemoglobin in red blood cells (Millon et al., 2011; Nitin et
al., 2009; Rouach et al., 2008). Because of the lack of 2-NBDG information from blood, the
compartment models used for quantifying the glucose metabolic rate in PET studies cannot
be directly applied in this study (Dedeurwaerdere et al., 2005; Imamura et al., 2009;
Katsuyama et al., 2010).
Discussion
Potential radiation exposure limits the usage of the radioactively labeled 2-DG analog. In
contrast, 2-NBDG solves this issue by providing optical contrast with low toxicity and fast
clearance to urine (Millon et al., 2011). Previously it has been demonstrated that the uptake
of 2-NBDG correlates well with cellular metabolism in cell studies (Millon et al., 2011;
Nitin et al., 2009). In vitro studies have also confirmed that epileptic activity increases 2-
NBDG traffic in neurons and the glial network (Rouach et al., 2008; Inyushin et al., 2010).
Moving one step forward, our in vivo results, for the first time, have showed that 2-NBDG is
a good indicator of the hypermetabolism caused by epileptic seizures, and may provide a
new tool for optically identifying epileptic foci.
Although current optical methods can be used to localize cortical epileptic foci in vivo in an
open skull, it is still challenging to apply those methods in subcortical brain structures,
especially with an intact skull (Gratton and Fabiani, 2010; Koch et al., 2010). Brain tissue is
one of the worst materials for carrying light in the visual or the infrared part of the spectrum
(Kim et al., 2010b). Theoretically, it is possible to apply these techniques transcranially, for
human subject, especially for the infants, who have more transparent skull and smaller size
of the brain, but it needs substantial improvements on the hardware and software as well as
the contrast agents. In addition, some modern methods such as diffuse optical tomography
(DOT) and photoacoustic tomography (PAT) (Hielscher et al; 2002; Wang et al., 2003; Kim
et al., 2010b) may provide new directions. Like FDG used in PET, 2-NBDG has the
potential to be used in non-invasive brain imaging in PAT, a newly developed hybrid
modality which takes advantage of rich optical contrast and ultrasonic spatial resolution for
deep imaging (Kim et al., 2010b). PAT has highly scalable spatial resolution, imaging
speed, and penetration depth, determined by the system configurations (Kim et al., 2010a,
b). Using a modified clinical ultrasound array, a penetration depth of ~5 cm has been
demonstrated in biological tissue (Wang et al., 2002; Wang et al., 2003). Therefore, by
combining 2-NBDG with the excellent imaging capability of PAT, more applications in
metabolism-associated studies are expected in the future.
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Figure 1.
2-[N-(7-nitrobenz-2-oxa-1,3-diazol-4-yl)amino]-2-deoxy-D-glucopyranose (2-NBDG).
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Figure 2.
Experimental setup. Inset: cranial opening with microcapillary for intracortical injection. x:
rostral, y: lateral.
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Figure 3.
Time course of 2-NBDG accumulation at the injection sites of 4-AP (for epileptic activation,
green circles) and ACSF (control, blue circles).
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Figure 4.
Quantification of 2-NBDG accumulation. (A) The time courses of the normalized
fluorescence intensity around the injection sites of 4-AP (for epileptic activation) and ACSF
(control), respectively. The red arrow indicates the starting time of 2-NBDG injection via
the tail vein. Solid curves indicate the mean value; dashed curves show one standard
deviation above the mean. (B) Comparison of the stabilization times (defined as those times
reaching 90% of maxima) of 2-NBDG accumulation around the injection sites of 4-AP and
ACSF. Statistics: two-tailed paired student’s test. p value: 0.03. N = 5.
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